In stock
Metabolic Stack
Retatrutide · AOD-9604
Retatrutide · AOD-9604
£89.99
Free 24-hour delivery over £75 · Same-day dispatchOrder before 2pm - same-day dispatch · Free 24-hour delivery over £75
- Purity
- ≥ 99% HPLC
- Form
- Research stack: 4 lyophilised vials
- Origin
- United States
Manufactured for laboratory research. Not for human or veterinary use. Read full disclaimer →
A tissue-repair research bundle: KPV (10mg), BPC-157 (5mg), TB-500 (5mg) and GHK-Cu (50mg) for studies into tissue-repair, inflammatory-pathway and matrix-remodelling research.
- KPV, 10mg (1 vial)
- BPC-157, 5mg (1 vial)
- TB-500, 5mg (1 vial)
- GHK-Cu, 50mg (1 vial)
- Each compound independently identity and purity tested
- For laboratory research use only; not for human or veterinary use
What is the KLOW Stack?
The KLOW Stack is a research bundle of four separate lyophilised vials supplied as reference compounds for non-clinical laboratory research: KPV (10mg), BPC-157 (5mg), TB-500 (5mg) and GHK-Cu (50mg). "KLOW" is the established community shorthand for this particular four-compound grouping (the letters trace to the constituents), and it is the name buyers most often search for. The vials are not pre-mixed: each compound is a distinct reference material in its own sealed vial. For laboratory research use only. Not for human or veterinary use.
What is in the KLOW Stack?
The bundle contains one vial of each of the following, each linking to its own product page for full chemistry and batch detail: KPV (10mg), BPC-157 (5mg), TB-500 (5mg) and GHK-Cu (50mg). Each is an independently manufactured and tested reference compound, supplied as a lyophilised solid.
Is the KLOW Stack legal in the UK?
The compounds in this bundle are not controlled drugs under the Misuse of Drugs Act 1971. They are supplied strictly as reference materials for in-vitro laboratory research and are not medicines, foods, supplements or cosmetics. They are not for human or veterinary consumption. The buyer is responsible for handling, storing and using the materials in compliance with all applicable laws and institutional rules. See the research disclaimer for the full terms of supply.
Why are these compounds offered as one bundle?
Each of KPV, BPC-157, TB-500 and GHK-Cu has its own separate body of published non-clinical literature, set out on each constituent product page. They are offered together purely as a sourcing convenience, so a laboratory can obtain four distinct reference compounds in a single order. The grouping is not presented as a combined preparation and no combined effect is claimed or implied; supplying the vials together does not produce any outcome. For the chemistry and batch detail of each compound, follow the links on the constituent product pages above.
How is quality assured?
Each compound in the bundle is released only after independent third-party testing, with purity assessed by HPLC at 99% or higher and identity confirmed against the expected mass. A Certificate of Analysis is available for every batch. Browse current batch documents on the Certificates of Analysis page.
Supply and reconstitution
The four compounds ship as separate lyophilised vials, not as a combined preparation. Laboratories typically reconstitute lyophilised reference peptides with a suitable laboratory solvent following their own standard operating procedures. Store the sealed lyophilised vials at -20C, kept dry and protected from light, and hold any reconstituted material at 2-8C. Refer to each constituent product page for compound-specific handling, and to the research disclaimer for the conditions of supply. For laboratory research use only. Not for human or veterinary use.
External resources for researchers
- Product name
- KLOW Stack
- Form
- Research stack: 4 lyophilised vials
- Solubility
- Bacteriostatic water
- Storage
- Lyophilised: store at -20C, dry and light-protected. Reconstituted: 2-8C.
- What is the KLOW Stack?
- It is a research bundle of four separate lyophilised vials supplied as reference compounds for non-clinical laboratory research: KPV (10mg), BPC-157 (5mg), TB-500 (5mg) and GHK-Cu (50mg). The vials are not pre-mixed. For laboratory research use only; not for human or veterinary use.
- What is in the KLOW Stack?
- Four separate vials, one of each compound: KPV (10mg), BPC-157 (5mg), TB-500 (5mg) and GHK-Cu (50mg). Each constituent links to its own product page for full chemistry and batch detail.
- Is this the KLOW stack people search for?
- Yes. KLOW is the established community shorthand for this four-compound grouping (the letters trace to the constituents). We use the nickname only to identify the bundle; it is not a description of any effect.
- What is the difference between KLOW and GLOW?
- It is a difference of composition only. GLOW refers to the three-compound grouping of GHK-Cu, BPC-157 and TB-500. KLOW is the same three compounds with KPV (10mg) added, making four vials in total. Neither name describes an outcome; both are search shorthand for which reference compounds are included.
- Is the KLOW Stack legal to buy in the UK?
- The compounds are not controlled drugs under the Misuse of Drugs Act 1971 and are supplied as reference materials for in-vitro laboratory research only. They are not medicines, supplements or cosmetics, and the buyer is responsible for compliance with all applicable laws and institutional rules.
- Is the KLOW Stack for human use?
- No. The bundle is strictly for in-vitro laboratory research. It is not a medicine, food, supplement or cosmetic and is not intended or supplied for human or veterinary use.
- Have these compounds been shown to be safe or effective together in humans?
- No. We make no such claim. The constituents are sold together only as a sourcing convenience of separate reference materials. They are not presented as a combined preparation and no combined effect is claimed or implied. No human or veterinary use is intended or implied.
- Why are these particular compounds grouped in one bundle?
- Each of KPV, BPC-157, TB-500 and GHK-Cu has its own separate body of published non-clinical literature, set out on its own product page. They are offered together purely so a laboratory can source four distinct reference compounds in one order, not because grouping them produces any outcome. See each constituent product page for detail.
- Are all four vials the same quality, and is there a CoA?
- Yes. Each compound is independently third-party tested, with purity assessed by HPLC at 99% or higher and identity confirmed against the expected mass. A Certificate of Analysis is available for every batch on our Certificates of Analysis page.
- How is the KLOW Stack supplied and reconstituted?
- As four separate lyophilised vials, not a combined preparation. Laboratories typically reconstitute lyophilised reference peptides with a suitable laboratory solvent following their own standard operating procedures. Refer to each constituent product page for compound-specific handling.
- How should the vials be stored?
- Store the sealed lyophilised vials at -20C, kept dry and protected from light. Hold any reconstituted material at 2-8C. See each constituent product page for compound-specific storage detail.
- Is the KLOW Stack despatched from the UK?
- Yes. Orders are despatched from the UK. All items are supplied as reference materials for laboratory research use only; not for human or veterinary use.
No third-party batch reports have been uploaded for this product yet. Reports are issued by independent labs after each manufacturing batch.
Calculator
Research planning only
Concentration2.50 mg/ml
Volume to draw0.100 ml
Insulin syringe (100 IU/ml)
10.0units
For research planning only. Not medical, dosing, or therapeutic advice. All Kovalabs products are research-use-only.
Store unreconstituted vials at −20°C for long-term, or refrigerated at 2-8°C for short-term use. Avoid repeated freeze-thaw cycles.
Reconstitute with bacteriostatic water down the inside wall of the vial; gently swirl to dissolve. Do not shake.
Once reconstituted, refrigerate at 2-8°C and use within 2-4 weeks. Discard if cloudy, discoloured, or particulate.
